FindTrial
Sign In

Reassessment of risk in hypertension patients at high cardiovascular risk

Reassessment of risk in hypertension patients at high cardiovascular risk and relationship between nitric oxide and cardiovascular events in resistant hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056125
Enrollment
Unknown
Registered
2022-02-01
Start date
2015-01-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Training group:None
Validation group:None

Sponsors

First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Office systolic blood pressure (BP) more than 140 mmHg and/or diastolic BP more than 90 mmHg (average of 3 repeated measurements made by the same doctor with a sphygmomanometer), or patients with systolic BP more than 135 mmHg and/or diastolic BP more than 85 mmHg by daytime ambulatory BP monitoring. 2. 18 years of age or older. 3. Risk stratification was carried out according to 2018 Chinese Guidelines for Prevention and Treatment of Hypertension, and the hypertensive patients were identified as high-risk or very high-risk.

Exclusion criteria

Exclusion criteria: 1. Cardiovascular and cerebrovascular diseases within 3 months; 2. Combined pregnancy; 3. Complicated with renal failure; 4. Severe liver failure; 5. Complicated with malignant tumor; 6. Patients who loss to follow-up.

Design outcomes

Primary

MeasureTime frame
Cardiovascular events;—

Countries

China

Contacts

Public ContactWenjie Yin

First Hospital of Shanxi Medical University

yinwenjie119@126.com+86 13835181421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026